Melatonin için Sleep-Related Cognitive Impairment

Q: Does Melatonin help with Sleep-Related Cognitive Impairment?

Based on 15 studies with 2,000 participants, there is limited but promising evidence that Melatonin may support Sleep-Related Cognitive Impairment management. Our evidence grade is C (Some Evidence).

Q: How much Melatonin should I take for Sleep-Related Cognitive Impairment?

Studies have used various dosages. A commonly studied range is 0.5-5 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Melatonin?

Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Melatonin and Sleep-Related Cognitive Impairment?

We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dsleep\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Sonuç

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

Key Study Findings

review

Pediatric Insomnia.

Dose: Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) vs: Placebo Etki: CBT-I most effective treatment; melatonin beneficial in children with ASD or ADHD; limited evidence None

Other

Banxia Shumi Decoction Improves Sleep and Neural Function in Insomnia Male Rats via BDNF/TrkB/CREB-Dependent Melatonin …

Dose: None vs: PCPA-induced insomnia model control Outcome: Sleep quality and cognitive function in rat model Etki: None None

Popülasyon: PCPA-induced insomnia male rats

Randomized Controlled Trial n=322 5 weeks Double-blind

Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, …

Dose: 20 mg or 50 mg tasimelteon daily vs: Placebo Outcome: Latency to persistent sleep (PSG) Etki: -44.9 min (20mg) / -46.3 min (50mg) vs -28.2 (placebo) <0.001

Popülasyon: Patients with primary insomnia (sleep onset difficulty)

Review

Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment.

Dose: None vs: None Outcome: ISWRD symptom management Etki: None None

Popülasyon: Patients with irregular sleep-wake rhythm disorder

review

Insomnia in older adults: A review of treatment options.

Dose: various vs: Placebo Etki: None None

Review

Commonly encountered symptoms and their management in patients with cirrhosis.

Dose: None vs: None Outcome: Pain outcomes Etki: None None

Popülasyon: Insomnia patients

Key Statistics

Çalışmalar

2000

Katılımcılar

↑

Positive

Derece

Referenced Papers

Pediatric Insomnia. Review

Pediatrics in review 2026

Insomnia in older adults: A review of treatment options. Review

Cleveland Clinic journal … 2025 12 atıf

Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment. Review

Handbook of clinical … 2025 4 atıf

Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial. RCT

PloS one 2025 1 atıf

Banxia Shumi Decoction Improves Sleep and Neural Function in Insomnia Male Rats via BDNF/TrkB/CREB-Dependent Melatonin Signaling Activation. Other

Neurochemical research 2025

Interventions for insomnia in cancer patients and survivors-a comprehensive systematic review and meta-analysis. Meta-Analysis

JNCI cancer spectrum 2024 24 atıf

Evaluation and management of insomnia in the clinical practice in Italy: a 2023 update from the Insomnia Expert Consensus Group. Review

Journal of neurology 2024 21 atıf

Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Serotonin Receptor Activity in a Murine Model. Other

Antioxidants (Basel, Switzerland) 2024 17 atıf

Delayed sleep wake phase disorder in adolescents: an updated review. Review

Current opinion in … 2024 12 atıf

Commonly encountered symptoms and their management in patients with cirrhosis. Review

Frontiers in medicine 2024 4 atıf

[Pharmacotherapies for insomnia]. Other

La Revue du … 2024

Complementary and alternative treatments for insomnia disorder: a systematic umbrella review. Systematic Review

Journal of sleep … 2023 12 atıf

RP58 knockdown contributes to hypoxia-ischemia-induced pineal dysfunction and circadian rhythm disruption in neonatal rats. Other

Journal of pineal … 2023 7 atıf

Targeting neuroendocrine abnormalities in Parkinson's disease with exercise. Other

Frontiers in neuroscience 2023 5 atıf

The Involvement of Melatonin and Tasimelteon against Alzheimer's Disease. Review

Current drug safety 2023 2 atıf

Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial. Other

BMJ open 2022 3 atıf

Melatonin ameliorates Parkinson's disease via regulating microglia polarization in a RORα-dependent pathway. Other

NPJ Parkinson's disease 2022

Biological rhythms and chronotherapeutics in depression. Review

Progress in neuro-psychopharmacology … 2021 68 atıf

Circadian Rhythm Disorders and Corresponding Functional Brain Abnormalities in Young Female Nurses: A Preliminary Study. Other

Frontiers in neurology 2021 16 atıf

A Systematic Review of the Efficacy and Safety of Over-the-Counter Medications Used in Older People for the Treatment of Primary … Systematic Review

The Senior care … 2021 12 atıf

The role of pineal microRNA-325 in regulating circadian rhythms after neonatal hypoxic-ischemic brain damage. Other

Neural regeneration research 2021 6 atıf

Insomnia and menopause: a narrative review on mechanisms and treatments. Review

Climacteric : the … 2020 97 atıf

Sleep Issues in Parkinson's Disease and Their Management. Review

Neurotherapeutics : the … 2020 80 atıf

Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease. Review

Current treatment options … 2020 29 atıf

The effect of jet lag on the human brain: A neuroimaging study. Other

Human brain mapping 2020 15 atıf

Clinical Pearls on Sleep Management in Atopic Dermatitis. Review

Dermatitis : contact, … 2019 7 atıf

European guideline for the diagnosis and treatment of insomnia. Other

Journal of sleep … 2017 1691 atıf

A review of sleep disorders and melatonin. Review

Neurological research 2017 331 atıf

Dietary Sources and Bioactivities of Melatonin. Review

Nutrients 2017 301 atıf

Treatment of Sleep Dysfunction in Parkinson's Disease. Review

Current treatment options … 2017 56 atıf

Melatonin restores hippocampal neural precursor cell proliferation and prevents cognitive deficits induced by jet lag simulation in adult mice. Other

Journal of pineal … 2017 45 atıf

Review of Safety and Efficacy of Sleep Medicines in Older Adults. Review

Clinical therapeutics 2016 328 atıf

Pediatric Insomnia. Review

Chest 2016 109 atıf

Melatonin has multiorgan effects. Review

European heart journal. … 2016 77 atıf

Keeping circadian time with hormones. Review

Diabetes, obesity & … 2015 132 atıf

Assessment and treatment of insomnia in adult patients with alcohol use disorders. Review

Alcohol (Fayetteville, N.Y.) 2015 122 atıf

Treatment of chronic insomnia disorder in menopause: evaluation of literature. Review

Menopause (New York, … 2015 73 atıf

Air travel: effects of sleep deprivation and jet lag. Review

Chest 2013 53 atıf

Familial circadian rhythm disorder in the diurnal primate, Macaca mulatta. Other

PloS one 2012 14 atıf

Melatonin in experimental seizures and epilepsy. Review

Pharmacological reports : … 2011 99 atıf

Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? Review

Progress in neuro-psychopharmacology … 2011 71 atıf

[Insomnias. II. Pharmacological and psychotherapeutic treatment options]. Meta-Analysis

Der Nervenarzt 2009 6 atıf

Therapeutic options for sleep-maintenance and sleep-onset insomnia. Review

Pharmacotherapy 2007 117 atıf

[Rhythms, depressions and light]. Review

Tidsskrift for den … 2006

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Other

Brain research. Molecular … 2005 160 atıf

Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Other

Reviews of reproduction 1998 381 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:: 0.5-5 mg/day
sleepcognitivesupport:: 0.5-3 mg 30-60 min before bed

Üst sınır: 10 mg/day (higher doses not more effective)

Araştırmalarda İncelenen Dozajlar

Dozaj	Süre	Etki	N
Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other)	--	Positive	--
None	--	Positive	--
20 mg or 50 mg tasimelteon daily	5 weeks	Positive	322
None	--	Mixed	--
various	--	Positive	--
None	--	Neutral	--
None	--	Positive	6528
Z-drugs, melatonin, orexin antagonists	--	Positive	--

En iyi alım zamanı: 30-60 minutes before bedtime

Safety & Side Effects

Bildirilen Yan Etkiler

⚠ Daytime drowsiness
⚠ Headache
⚠ Dizziness
⚠ Nausea
⚠ Vivid dreams

Bilinen Etkileşimler

● Sedative medications (additive drowsiness)
● Blood thinners (may increase bleeding risk)
● Diabetes medications (may affect blood sugar)
● Immunosuppressants (may stimulate immune function)
● Oral contraceptives (may increase melatonin levels)

Tolere edilebilir üst alım: 10 mg/day (higher doses not more effective)

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Melatonin help with Sleep-Related Cognitive Impairment?

Based on 15 studies with 2,000 participants, there is limited but promising evidence that Melatonin may support Sleep-Related Cognitive Impairment management. Our evidence grade is C (Some Evidence).

How much Melatonin should I take for Sleep-Related Cognitive Impairment?

Studies have used various dosages. A commonly studied range is 0.5-5 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Melatonin?

Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Melatonin and Sleep-Related Cognitive Impairment?

We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

Şu durum için diğer içerikler: Sleep-Related Cognitive Impairment

Ashwagandha C L-Theanine C Magnesium L-Threonate C Creatine C

Hızlı Değerlendirme

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

Evidence Strength52%

Moderate confidence

Çalışma Dağılımı

RCT (1)Meta (2)Other (12)

Alternatifleri Karşılaştır

Bu durum için diğer bileşenlerin nasıl karşılaştırıldığını görün.Diğer içeriklerin bu sağlık durumu için nasıl karşılaştırıldığını görün.

Şu durum için tüm içerikleri görüntüle: Sleep-Related Cognitive Impairment

Daha Fazla Bilgi

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.